Inflammation and Cardiac Diseases de Giora Z. Feuerstein

Inflammation and Cardiac Diseases: Progress in Inflammation Research

Giora Z. Feuerstein

Peter Libby

Douglas L. Mann

en Limba Engleză Paperback – 23 oct 2012

Heart failure research is a most active area of research in academic, industrial and government-sponsored research and receives intense clinical attention. The recent recognition that inflammation is a risk factor and prognostic factor for heart disease has laid ground for preventive medicine and even anti-infective strategies in prevention and treatment of heart failure.

Citește tot Restrânge

	Preț	Express
Paperback (1)	1141^.57 lei 6-8 săpt.
Birkhäuser Basel – 23 oct 2012	1141^.57 lei 6-8 săpt.
Hardback (1)	1094^.10 lei 6-8 săpt.
Birkhäuser Basel – 25 aug 2003	1094^.10 lei 6-8 săpt.

Preț

Express

Paperback (1)

1141^.57 lei 6-8 săpt.

Birkhäuser Basel – 23 oct 2012

1141^.57 lei 6-8 săpt.

Hardback (1)

1094^.10 lei 6-8 săpt.

Birkhäuser Basel – 25 aug 2003

1094^.10 lei 6-8 săpt.

Din seria Progress in Inflammation Research

5%

Preț: 1582^.27 lei
5%

Preț: 1404^.03 lei
5%

Preț: 708^.44 lei
18%

Preț: 930^.96 lei
15%

Preț: 635^.31 lei
5%

Preț: 1274^.34 lei
5%

Preț: 1081^.59 lei
5%

Preț: 1061^.93 lei
5%

Preț: 700^.90 lei
5%

Preț: 1076^.37 lei
5%

Preț: 644^.63 lei
5%

Preț: 703^.43 lei
5%

Preț: 996^.71 lei
5%

Preț: 1385^.03 lei
5%

Preț: 1080^.12 lei
5%

Preț: 1080^.47 lei
5%

Preț: 991^.70 lei
5%

Preț: 1093^.24 lei
5%

Preț: 705^.74 lei
5%

Preț: 1579^.06 lei
5%

Preț: 641^.03 lei
5%

Preț: 1385^.95 lei
5%

Preț: 639^.61 lei
5%

Preț: 1077^.64 lei
5%

Preț: 1818^.92 lei
15%

Preț: 631^.92 lei
5%

Preț: 1086^.24 lei
5%

Preț: 645^.16 lei
5%

Preț: 1086^.05 lei
24%

Preț: 801^.38 lei
5%

Preț: 700^.73 lei
5%

Preț: 1770^.39 lei
5%

Preț: 706^.82 lei
5%

Preț: 991^.70 lei
5%

Preț: 706^.10 lei
5%

Preț: 1077^.79 lei
15%

Preț: 566^.19 lei
5%

Preț: 639^.61 lei
5%

Preț: 640^.15 lei
5%

Preț: 637^.12 lei
5%

Preț: 1094^.10 lei
5%

Preț: 1074^.75 lei
5%

Preț: 1383^.96 lei
5%

Preț: 1391^.67 lei
5%

Preț: 707^.16 lei
5%

Preț: 1079^.77 lei
5%

Preț: 1076^.92 lei

Cuprins

Inflammation – a new frontier in cardiac disease and therapeutics.- Pathological aspects and inflammation biomarkers in cardiac diseases.- A biomarker of inflammation in cardiovascular diseases.- Inflammation and coronary artery disease.- Inflammatory cells and their metalloproteinases in cardiac diseases.- The role of matrix metalloproteinases in LV remodeling following myocardial infarction.- Matrix metalloproteinases in heart failure: evidence from experimental models.- Inflammatory cytokines in cardiac diseases.- The clinical experience with anti-cytokine therapy in heart failure.- The role of IL-6 and related cytokines in myocardial remodeling and inflammation – implication for cardiac hypertrophy and heart failure.- Toll-like receptors and the cardiovascular system.- The role of IL-6 in experimental and clinical heart failure.- Oxygen and nitrogen reactive radicals in cardiac inflammation and disease.- Myocardial nitric oxide in cardiac remodeling.- Identification and role of inflammatory oxygen free radicals in cardiac ischemia and reperfusion injury.- The immune and complement system and cardiac diseases.- Immune-mediated myocarditis and interleukin-10.- Immunomodulation in heart failure: experimental models.- The role of complement in myocardial inflammation and reperfusion injury.- Inflammatory signaling pathways in cardiac diseases.- The role of immune and inflammatory cytokines in ischemic preconditioning of the heart – identification of novel cardiac cell survival signaling programs.- Stress-activated signals and their role in myocardial ischemia.- p38 MAPK in cardiac remodeling and failure: cytokine signaling and beyond.- Inflammation and myocarditis.- Inflammation and myocarditis.- The inflammatory process in experimental myocarditis.- Nuclearfactors in cardiac disease.- Peroxisome proliferator activated receptors, inflammation, the vasculature and the heart.- Chemokines and cardiac diseases.- Role of chemokines in the pathogenesis of congestive heart failure.- Neurohormonal mediators and cardiac inflammation.- The role of endothelin-1 in myocardial inflammation and fibrosis.- Cyclooxygenases and cardiac diseases.- Cyclo-oxygenase-2 and myocardial ischemia.- Inflammation and arrhythmias.- Inflammation as a cause and consequence of atrial fibrillation.- Summary: Immune and inflammatory modulators as potential therapeutic targets for cardiac diseases.